• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Obesity associated with higher early-onset cancer risk among young Korean adults

byAdrian Wong, BHScandDeepti Shroff, DMD, MS
November 13, 2026
in Chronic Disease, Endocrinology, Oncology, Public Health
Reading Time: 3 mins read
Obesity measurement collage: a bathroom scale with a blank dial, a loose cloth measuring tape, an apple and a pear
Share on FacebookShare on TwitterShare on LinkedIn

1. In this cohort study, obesity, measured by body mass index (BMI) and waist circumference, was associated with higher early-onset cancer risk among Korean adults aged 20 to 39.

2. Thyroid, endometrial, and ovarian cancer had the highest 10-year cumulative incidence but endometrial cancer had the strongest relative association with obesity.

Evidence Rating Level: 2 (Good)

Study Rundown: The global prevalence of obesity has increased sharply in recent decades, reaching around 15% in men and 21% in women in 2021. Around 10% of cancer incidence worldwide in 2021 could be attributed to overweight or obesity, making it 1 of the 3 biggest contributors to cancer risk, after smoking and infection. The increasing prevalence of obesity and incidence of early-onset cancer among young people poses new challenges for public health. This study aimed to assess dose-response relationships between obesity and overall cancer incidence among Korean adults aged 20 to 39 and evaluate how they may be affected by age, sex, and smoking status. Both class I and class II obesity were associated with higher absolute and relative cancer risk compared with normal weight. The relative association between overweight or obesity and overall cancer was more apparent in men, while the absolute risk difference was higher in women. Abdominal obesity was also more strongly linked to cancer risk across all BMI categories, with the absolute risk difference associated with abdominal obesity being larger at higher BMI levels. Relative associations between obesity and cancer were more apparent among people with a smoking history, whereas absolute risk differences were similar between ever-smokers and never-smokers. Cancer risk was progressively higher with greater obesity for obesity-related cancers with consistent definitions. The highest 10-year cumulative incidence and risk differences were seen for thyroid, endometrial, and ovarian cancer, whereas endometrial cancer had the highest relative risk in people with obesity. This study has a few limitations. Due to its retrospective nature, a causal relationship between obesity and early onset cancer cannot be established. Factors such as dietary patterns, physical activity, family medical history, consumption of alcohol could affect the observed associations and were not accounted for. Last but not least, since the population consisted of young Korean adults, the findings may not be widely generalizable to other ethnic populations. Nevertheless, this study suggests that obesity, especially abdominal obesity, is associated with increased cancer risk among young people, thus highlighting obesity as a potentially important factor in early-onset cancer risk.

Click to read this study in the Annals of Internal Medicine

Relevant Reading: Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

RELATED REPORTS

First-trimester doxycycline exposure may be linked to higher risk of pregnancy loss

2 Minute Medicine Rewind November 9, 2026

FDA approvedFor obesity: Foundayo (orforglipron), Apr 1, 2026→

In-Depth [retrospective cohort]: This cohort study aimed to assess associations between obesity and early-onset cancer risk in young Korean adults. Data for 6,891,401 people aged 20 to 39 years who underwent a national health examination between January 1, 2009, and December 31, 2012, were initially included. People diagnosed with cancer prior to the index date (n = 23,070) and people with missing data on key variables (n = 554,993) were excluded. The primary outcome was development of newly diagnosed cancer, whereas secondary outcomes included the incidence of site-specific cancer. A final cohort of 6,313,338 Korean adults was included, with a mean age of 30.9 years and with men making up 59.3% of the study population. A total of 151,893 incident cancer cases (2.4%) were reported during a mean follow-up of 11.2 years. Both class I and class II obesity were associated with higher absolute and relative cancer risk compared with normal weight. Cumulative incidence increased with higher BMI, ranging from 1.84% (95% CI, 1.83% to 1.86%) in the normal-weight group to 2.24% (CI, 2.22% to 2.27%) in class I obesity and 2.62% (CI, 2.56% to 2.68%) in class II obesity. Cancer risk was consistently higher with abdominal obesity across all BMI categories. People with class I obesity based on BMI and with abdominal obesity had higher 10-year cumulative incidence (2.45% [CI, 2.41% to 2.50%]) than those without abdominal obesity (2.13% [CI, 2.10% to 2.16%]), exceeding that of those with class II obesity without abdominal obesity (2.20% [CI, 2.03% to 2.36%]). Cancer risk was progressively higher with higher adiposity for obesity-related cancers with consistent definitions, with 10-year cumulative incidence ranging from 1.15% (CI, 1.14% to 1.16%) in the normal-weight group to 1.57% (CI, 1.55% to 1.60%) in class I obesity and 1.95% (CI, 1.89% to 2.00%) in class II obesity. The individual cancers with the highest 10-year cumulative incidence and risk differences were thyroid, endometrial, and ovarian cancer. Overall, this study suggested that obesity may be associated with increased cancer risk among young Koreans.

Citation: Yun JS, Mun H, Jung JH, Park Y, Kim SY, Kim K, et al. Obesity and Cancer Risk in Young Adults in Korea : A Nationwide Health Screening Cohort Study. Ann Intern Med. 2026 Oct 26. doi: 10.7326/annals-25-02612. Epub ahead of print. PMID: 42932883.

© 2026 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: © 2 Minute Medicine

Tags: adultscancercancer riskobesityrisk
Previous Post

VS-041 reduced NT-proBNP after 28 days in a phase 1c HFpEF trial

RelatedReports

Miscarriage collage of a sprig of small white flowers, two mugs side by side and a folded knitted blanket on torn paper
All Specialties

First-trimester doxycycline exposure may be linked to higher risk of pregnancy loss

November 10, 2026
A profile of a human head with a visible brain, surrounded by descending bar graphs and doors leading into a fading background, suggesting themes of dementia and cognitive decline.
Weekly Rewinds

2 Minute Medicine Rewind November 9, 2026

November 11, 2026
A variety of pharmaceutical items including a vial, capsule, molecule model, pill blister pack, petri dish with a pipette, and a graph, symbolizing drug development.
Pharma Roundup

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

November 9, 2026
Heart catheter procedures collage: a smiling older man with a white beard and an engraved heart with a blue guidewire
Cardiology

In At-Risk Patients With Moderate Aortic Stenosis, TAVR Reduced 2-Year Death or Heart-Failure Events

November 8, 2026
✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Obesity associated with higher early-onset cancer risk among young Korean adults
  • VS-041 reduced NT-proBNP after 28 days in a phase 1c HFpEF trial
  • Ibuprofen is associated with acute kidney injury in high-risk inpatients but not low-risk.
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.